{"filing":{"accession_number":"0001628280-26-045804","cik":"0001855175","ticker":"CTNM","company_name":"Contineum Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-26","report_date":null,"primary_document":"ctnm-20260626.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1855175/000162828026045804/ctnm-20260626.htm"},"events":[{"id":14323,"run_id":12747,"accession_number":"0001628280-26-045804","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 26, 2026. The filing reports voting outcomes for two proposals: (1) election of three Class II directors (Evert Schimmelpennink, Lori M. Lyons-Williams, and Diego Miralles, M.D.) and (2) ratification of Ernst \u0026 Young LLP as the independent registered public accounting firm. This is a routine but material governance event that affects investor understanding of board composition and auditor selection.","company_name":"Contineum Therapeutics, Inc.","ticker":"CTNM","filing_date":"2026-06-26","form":"8-K","submitted_at":null,"items":[{"id":11713,"accession_number":"0001628280-26-045804","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 26, 2026. The filing reports voting outcomes for two proposals: (1) election of three Class II directors (Evert Schimmelpennink, Lori M. Lyons-Williams, and Diego Miralles, M.D.) and (2) ratification of Ernst \u0026 Young LLP as the independent registered public accounting firm. This is a routine but material governance event that affects investor understanding of board composition and auditor selection.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:50:08.967174+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11713,"accession_number":"0001628280-26-045804","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 26, 2026. The filing reports voting outcomes for two proposals: (1) election of three Class II directors (Evert Schimmelpennink, Lori M. Lyons-Williams, and Diego Miralles, M.D.) and (2) ratification of Ernst \u0026 Young LLP as the independent registered public accounting firm. This is a routine but material governance event that affects investor understanding of board composition and auditor selection.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:50:08.967174+00:00","company_name":"Contineum Therapeutics, Inc.","ticker":"CTNM","filing_date":"2026-06-26"}]}